ABT vs ALLY · P/E 25, rev $44.33B vs P/E 65, rev $7.91B
Abbott Laboratories (ABT) versus Ally Financial Inc (ALLY) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Ally Financial Inc (ALLY) is a credit services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ALLY revenue for 2025-12-31 was $7.91B. Net income was $852.0M. Revenue was down 3.3% from 2024-12-31 to 2025-12-31. ALLY currently screens at market cap $11.95B and trailing P/E 64.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ALLY currently screens at market cap $11.95B and trailing P/E 64.8.
Not investment advice. Open the ABT and ALLY stock pages for the full models.
Not investment advice.